Last updated on October 2018

Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation


Brief description of study

The purposes of the clinical trial are to determine whether the SA4Ag vaccine can prevent postoperative Staphylococcus aureus infections in patients who are undergoing elective spinal fusion surgery, and to evaluate the safety of SA4Ag in patients who are undergoing elective spinal surgery.

Clinical Study Identifier: NCT02388165

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

Nagasaki Rosai Hospital
Sasebo, Japan
1.95miles
  Connect »